Kaempferol Identified by Zebrafish Assay and Fine Fractionations Strategy from Dysosma versipellis Inhibits Angiogenesis through VEGF and FGF Pathways

被引：0

作者：

Fang Liang

Yuxiang Han

Hao Gao

Shengchang Xin

Shaodan Chen

Nan Wang

Wei Qin

Hanbing Zhong

Shuo Lin

Xinsheng Yao

Song Li

机构：

[1] Key Laboratory of Chemical Genomics,Department of Biology

[2] School of Chemical Biology and Biotechnology,Department of Molecular

[3] Peking University Shenzhen Graduate School,undefined

[4] Institute of Traditional Chinese Medicine & Natural Products,undefined

[5] College of Pharmacy,undefined

[6] Jinan University,undefined

[7] South University of Science and Technology of China,undefined

[8] Cell and Developmental Biology,undefined

[9] University of California,undefined

[10] Los Angeles,undefined

来源：

Scientific Reports | / 5卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Natural products are a rich resource for the discovery of therapeutic substances. By directly using 504 fine fractions from isolated traditional Chinese medicine plants, we performed a transgenic zebrafish based screen for anti-angiogenesis substances. One fraction, DYVE-D3, was found to inhibit the growth of intersegmental vessels in the zebrafish vasculature. Bioassay-guided isolation of DYVE-D3 indicates that the flavonoid kaempferol was the active substance. Kaempferol also inhibited the proliferation and migration of HUVECs in vitro. Furthermore, we found that kaempferol suppressed angiogenesis through inhibiting VEGFR2 expression, which can be enhanced by FGF inhibition. In summary, this study shows that the construction of fine fraction libraries allows efficient identification of active substances from natural products.

引用

共 92 条

[21] Lin S(2009)Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells Nutr Cancer 61 554-246
[22] Chen JN(2003)Involvement of the Akt/PKB signaling pathway with disease processes Molecular and Cellular Biochemistry 253 241-2012
[23] Rubinstein AL(2007)Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition Cellular Signalling 19 2003-1131
[24] Cooney MM(2007)Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF Biomaterials 28 1123-10672
[25] van Heeckeren W(2000)Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase Journal of Biological Chemistry 275 10661-789
[26] Bhakta S(2008)Chemical Fingerprinting of Medicinal Plants “Gui-jiu” by LC-ESI Multiple-Stage MS Chromatographia 68 781-120
[27] Ortiz J(2000)Podophyllotoxin Phytochemistry 54 115-265
[28] Remick SC(2008)Antiangiogenic effects of flavonoids and chalcones Pharmacological Research 57 259-207
[29] Tran TC(2001)FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition Trends in Pharmacological Sciences 22 201-37
[30] Ferrara N(2014)Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29 human colon cancer cells International journal of molecular sciences 15 2722-328

← 1 2 3 4 5 6 7 8 9 10 →